IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

LUBRANO DI SCORPANIELLO, Ennio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.820
EU - Europa 11.522
AS - Asia 4.510
SA - Sud America 1.352
AF - Africa 561
Continente sconosciuto - Info sul continente non disponibili 503
OC - Oceania 29
Totale 36.297
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.421
RU - Federazione Russa 4.924
SG - Singapore 1.978
IE - Irlanda 1.964
IT - Italia 1.126
BR - Brasile 991
CN - Cina 902
FR - Francia 586
UA - Ucraina 549
DE - Germania 486
FI - Finlandia 461
AT - Austria 374
GB - Regno Unito 360
CI - Costa d'Avorio 358
VN - Vietnam 344
SE - Svezia 335
BD - Bangladesh 235
HK - Hong Kong 219
CA - Canada 196
IN - India 192
AR - Argentina 103
MX - Messico 84
CO - Colombia 82
IQ - Iraq 70
TR - Turchia 70
JP - Giappone 69
ZA - Sudafrica 65
ID - Indonesia 63
NL - Olanda 61
PL - Polonia 61
EC - Ecuador 60
VE - Venezuela 48
ES - Italia 46
PK - Pakistan 45
BE - Belgio 42
SA - Arabia Saudita 39
PH - Filippine 31
LT - Lituania 28
MA - Marocco 26
MY - Malesia 26
AU - Australia 23
JM - Giamaica 22
IL - Israele 21
AZ - Azerbaigian 20
CL - Cile 20
UZ - Uzbekistan 20
CR - Costa Rica 19
IR - Iran 19
KR - Corea 18
TN - Tunisia 18
EG - Egitto 17
KZ - Kazakistan 17
RO - Romania 17
JO - Giordania 16
BO - Bolivia 14
EU - Europa 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
KE - Kenya 13
PE - Perù 13
NP - Nepal 12
SC - Seychelles 12
CZ - Repubblica Ceca 11
PA - Panama 11
TH - Thailandia 11
TT - Trinidad e Tobago 11
UY - Uruguay 11
AL - Albania 10
HN - Honduras 10
HR - Croazia 10
PY - Paraguay 10
CH - Svizzera 9
NI - Nicaragua 9
PT - Portogallo 9
BG - Bulgaria 8
GR - Grecia 8
GT - Guatemala 8
KG - Kirghizistan 8
OM - Oman 8
SV - El Salvador 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
SN - Senegal 7
GE - Georgia 6
EE - Estonia 5
LB - Libano 5
LK - Sri Lanka 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
AO - Angola 4
DK - Danimarca 4
KW - Kuwait 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
CY - Cipro 3
GI - Gibilterra 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LC - Santa Lucia 3
Totale 35.752
Salva come PNG Salva come JPEG
Città #
Dallas 4.426
Dublin 1.963
San Jose 1.768
Moscow 1.655
Jacksonville 1.330
Chandler 1.133
Ashburn 1.062
Singapore 1.047
The Dalles 434
Wilmington 411
Council Bluffs 394
Vienna 366
Abidjan 358
Rome 318
Helsinki 316
Houston 281
Beijing 273
San Mateo 248
Lauterbourg 227
Los Angeles 224
Hong Kong 212
Milan 211
Princeton 201
Santa Clara 197
Ann Arbor 185
New York 177
Boardman 150
Woodbridge 146
Ho Chi Minh City 125
Frankfurt am Main 114
Columbus 108
São Paulo 98
Dearborn 94
Phoenix 80
Orem 69
Tokyo 63
Hanoi 62
Chicago 59
San Francisco 58
Atlanta 56
Seattle 55
Brooklyn 54
Toronto 54
Denver 53
Montreal 52
Warsaw 50
Miano 44
Amsterdam 43
Charlestown 42
London 41
Redwood City 41
Rio de Janeiro 40
Apopka 38
Chennai 38
Johannesburg 37
Mountain View 36
Brussels 35
Grover Beach 34
Molise 34
Mexico City 33
Boston 29
Hillsboro 29
Manchester 29
Dhaka 28
Janesville 27
Jinan 27
Nuremberg 25
Baghdad 24
Caracas 23
Bogotá 22
Kirkland 22
Naples 22
Brasília 21
Shanghai 21
Baku 19
Istanbul 19
Lahore 19
Nanjing 19
Falls Church 18
Guangzhou 18
Quito 18
Shenyang 18
Tashkent 18
Mumbai 17
Ottawa 17
Buffalo 16
Jakarta 16
Las Vegas 16
Plymouth Meeting 16
Porto Alegre 15
San José 15
Amman 14
Augusta 14
Curitiba 14
Guayaquil 14
Ningbo 14
Stockholm 14
Washington 14
Auburn Hills 13
Belo Horizonte 13
Totale 22.320
Salva come PNG Salva come JPEG
Nome #
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action 2.744
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 364
An International Multidisciplinary Delphi-Based Consensus on Heat Therapy in Musculoskeletal Pain 304
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 263
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 227
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 225
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 219
An overview of low disease activity and remission in psoriatic arthritis. 218
An audit of anthropometric measurements by medical and physiotherapy staff in patients with ankylosing spondylitis 216
ANTHROPOMETRIC MEASUREMENTS AND DISABILITY IN A OPEN FOLLOW UP STUDY ON ANKYLOSING SPONDYLITIS WITH COMBINED MEDICAL AND REHABILITATIVE TREATMENT 208
Antiphospholipid syndrome, activated protein C resistance and mutation C -> T 677 in the MTHFR gene with juvenile pulmonary embolism. A case report 202
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 200
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 198
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 198
Aortic involvement in ankylosing spondylitis 197
A novel biological target for the treatment of psoriatic arthritis. 196
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 195
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 194
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 191
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 190
A rare enthesopathy in psoriatic oligoarthritis 187
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 182
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 182
La spondilodiscite delle spondiloartriti sieronegative 181
Measuring psoriatic disease in clinical practice. An expert opinion position paper. 180
A national survey on the management of psoriatic arthritis using the Delphi method 180
Iperuricemia e rischio cardio-renale 179
The arthritis of coeliac disease: prevalence and pattern in 200 adult patients 177
Simple clinical indicators for early psoriatic arthritis detection. 176
Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis 175
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 175
Assessment of psoriatic nail disease activity by rheumatologists 172
Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up 171
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 171
Venous thrombophilia in a patient with protein S deficiency, factor V Leiden and homozygous MTHFR C -> T677 mutation 170
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 170
Unmet needs in outcome measures of Psoriatic Arthritis: focus on axial radiographic and nail involvement 169
The arthritis of ulcerative colitis: clinical and genetic aspects 168
Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model 166
Pharmacoeconomic issues in psoriatic arthritis 164
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study 163
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 163
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 162
Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis? 161
Somatic perception in irritable bowel syndrome (IBS) patients with and without fibromyalgia (FMS). Does the severity of IBS influence the perception of somatic stimuli? 161
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 160
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 160
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 160
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 158
The performance of CASPAR criteria in early psoriatic arthritis - preliminary results from an Italian prospective multicentric study 158
Venous thrombophilia with severe mesenteric involvement associated to homozygosity for factor V Leiden and heterozygosity for G20210A mutation of prothrombin 158
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 157
Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions 156
Patient education in psoriatic arthritis: a cross sectional study on knowledge by a validated self-administered questionnaire 156
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 156
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? 155
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 153
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 153
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy 153
Consensus on the management of patients with psoriatic arthritis in a dermatology setting 152
LA COMPLICANZA ARTICOLARE DELLA MALATTIA CELIACA. STUDIO SU 62 CASI: RISULTATI PRELIMINARI 151
The role of IL-17 in the treatment of psoriatic arthritis 151
Axonal degeneration in systemic sclerosis can be reverted by factors improving tissue oxygenation 150
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study 149
Updated guidelines for the management of axial disease in psoriatic arthritis 149
Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies 149
Validity of the modified stoke ankylosing spondylitis spine score (M-SASSS) and of the bath ankylosing spondylitis radiology index (BASRI) for the radiological assessment of axial involvement in psoriatic arthritis. multicentre validation study. Part one. 148
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. 147
Psoriatic arthritis: imaging techniques 147
Fibromyalgia is strongly associated with the severity of inflammatory bowel syndrome. 147
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 147
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 146
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 146
New insights in occult psoriatic arthritis 146
The assessment of knowledge in ankylosing spondylitis patients by a self-administered questionnaire 145
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 145
An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis 144
Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis. 144
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology 144
Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis 143
Trauma and seronegative spondylarthropathy 143
Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: A systematic review. 143
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. 142
Subcorneal pustular dermatosis (Sneddon-Wilkinson syndrome): another cutaneous manifestation of SAPHO syndrome? 142
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 141
Emerging drugs for psoriatic arthritis 141
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 141
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: An extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 141
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 141
Unmet Needs in Axial Spondyloarthritis 141
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 141
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept 141
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review 140
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. 140
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 139
Physical trauma triggers psoriasis in a patient with undifferentiated seronegative spondyloarthropathy 139
Role of comorbidities in spondyloarthritis including psoriatic arthritis 139
18F-FDG PET/CT technology for the assessment of brown adipose tissue: an updated review 138
Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients. 138
Outcome measures in psoriatic arthritis 138
Totale 19.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 155.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022649 0 0 0 31 55 28 29 106 141 154 43 62
2022/20234.662 535 121 102 392 245 377 16 220 2.328 146 82 98
2023/2024855 238 133 55 21 30 72 18 47 19 47 84 91
2024/20253.476 460 120 432 92 544 143 60 258 306 114 431 516
2025/202617.071 455 1.664 3.317 926 3.192 2.686 1.600 581 596 1.424 385 245
2026/20274.047 467 761 1.558 1.261 0 0 0 0 0 0 0 0
Totale 36.297